Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

From The Embassy of Good Science
Revision as of 13:26, 19 August 2021 by 0000-0002-3240-4478 (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Cases

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

What is this about?

This factual case discusses various accusations of scientific misconduct, most notably the practices of guest authorship and ghostwriting. The case begins with various letters to the authors of an article on guest authorship and the editors of the journal, following which both the editors and the authors respond to these letters.

Why is this important?

Ghostwriting and guest authorship give an unfair advantage to guest authors over researchers who do not take part in such practices by awarding guest authors with publications despite not having contributed to the work done. In addition, the practice of guest authorship may seriously damage public trust in science and may also cast considerable doubt on the independence of researchers involved in drug trials. However, incorrect accusations of guest authorship, and scientific misconduct in general, harm the reputation of innocent researchers. Therefore, it is important to openly discuss accusations of guest authorship made in publications, as is done in the present case.

For whom is this important?

Other information

Cookies help us deliver our services. By using our services, you agree to our use of cookies.
5.1.6